CODX 8-K 2026-09-25
Co-Diagnostics, Inc. (CODX) 8-K dated 2026-09-25 — accession 0001493152-26-044346.
Co-Diagnostics, Inc. (CODX) is a medical devices company listed on US.
Co-Diagnostics, Inc. filed a 8-K on 2026-09-25. Accession 0001493152-26-044346.
This 8-K covers: Shareholder vote results (Item 5.07). SEC EDGAR holds the official filing and its exhibits.
Latest reported CODX revenue for 2025-12-31 was $622.5K. Net income was -$46.9M. Revenue was down 84.1% from 2024-12-31 to 2025-12-31. CODX currently screens at market cap $31.4M.
Not investment advice. The CODX SEC hub lists recent forms. The stock page is the research view.